Manufacturing AbbVie opts for North Carolina to house $1.4bn manufacturing site Pharmaceutical TechnologyThis Durham-based facility will be AbbVie's first manufacturing site in the state, and will become a centre of excellence for SVP production.ManufacturingRead full story pharminent April 23, 2026 (Last updated: April 23, 2026) Pharmaceutical Technology This Durham-based facility will be AbbVie’s first manufacturing site in the state, and will become a centre of excellence for SVP production. ManufacturingRead full story Post navigation Previous: MSD teams up with Google Cloud on agentic AI transformationNext: Sanofi receives FDA approval for Tzield in paediatric diabetes Related Stories Manufacturing Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar vision pharminent September 9, 2026 Manufacturing US puts $125m into personalised RNA therapy production pharminent September 2, 2026 Manufacturing Multispecifics are transforming the CDMO development architecture pharminent August 28, 2026